In the last years, major progress has occurred in heart failure (HF) management. The 2023 ESC focused update of the 2021 HF guidelines introduced new key recommendations based on the results of the last years of science. First, two drugs, sodium鈥揼lucose co-transporter-2 (SGLT2) ...
The 2023 update of the European Society of Cardiology (ESC) guidelines recommends (class IA) the administration of sodium-glucose transporter 2 inhibitors (SGLT2i) also for patients with heart failure with preserved ejection fraction (HFpEF) and mildly reduced EF (HFmrEF). Thus, SGLT2i are the...
Heart Failure Reviews (2024) A network medicine approach to study comorbidities in heart failure with preserved ejection fraction Jan D. Lanzer Alberto Valdeolivas Rebecca T. Levinson BMC Medicine (2023) Seasonality of acute kidney injury phenotypes in England: an unsupervised machine learning classi...
Heart failure (HF) remains a significant cardiovascular problem, with increasing incidence and prevalence rates: Adult Americans over 40 years of age have a 20 % lifetime risk of developing heart failure. Approximately five million people in the USA have
Heart failure with preserved ejection fraction (HFpEF) has grown to become the dominant form of heart failure worldwide, in tandem with ageing of the general population and the increasing prevalences of obesity, diabetes mellitus and hypertension. The clinical syndrome of HFpEF is heterogeneous and ...
Heart failure (HF) was the focus of the congress, accounting for nearly a third of the 30 Hot Line trials. In the STEP-HFpEF trial,1which included patients with HF with preserved ejection fraction (HFpEF) and o...
Heart failure (HF) is a heterogenous and life-threatening syndrome that affects more than 60 million individuals globally and is characterised by severe morbidity and mortality, poor quality of life, and a high burden on the healthcare systems in terms of resource use and expenditures.[1] The ...
Update on obesity, the obesity paradox, and obesity management in heart failure ? 2024 Elsevier Inc.Obesity is a major public health challenge worldwide. It is costly, predisposes to many cardiovascular (CV) diseases (CVD), is increasi... PL Alebna,A Mehta,A Yehya,... - 《Progress in ...
In this Review, Parati et al. outline the complex interactions between heart failure and sleep alterations, with a focus on sleep-disordered breathing, and describe the pathophysiology, diagnosis, and treatment of these sleep disorders. In the context of
Despite the indispensable role of self-care behavior in managing heart failure, the practice of self-care behavior remains poor, especially in developing countries. There is a scarcity of research focusing on poor self-care behavior and its determinants